Expected out-of-pocket costs for commonly prescribed brand name medications have grown substantially for Medicare Part D ...

A judge in California has ruled that a law banning so-called pay-to-delay deals between pharma companies cannot be enforced ...

Avenacy, a specialty pharmaceutical company focused on supplying critical injectable medications, today announced it has ...